NBIX vs TSM Stock Comparison

NBIX currently leads TSM in this stock comparison, with AIQ scores of 74 vs 67. The clearest difference is value.

Market data as of Nov 15, 2026 market close· AIQ score gap 7 points
NBIX
Healthcare
vs
TSM
Technology
NBIX
Neurocrine Biosciences, Inc.
Leads
Price
$167
Day move
-1.18%
AIQ Score
74/100
Best edge
Value
Sector
Healthcare
TSM
Taiwan Semiconductor Manufacturing Company Limited
Price
$399
Day move
-1.67%
AIQ Score
67/100
Best edge
Balanced
Sector
Technology

What is the main difference between NBIX and TSM?

NBIX leads the current stock comparison as Neurocrine Biosciences, Inc., with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

Neurocrine Biosciences, Inc. vs Taiwan Semiconductor Manufacturing Company Limited

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Technology· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 4/10

NBIX leads

NBIX leads by 7 AIQ points, primarily on Value and Risk Resilience, having only recently taken the lead back from TSM. Wall Street currently favors TSM on target upside.

Fragile: 4 of 6 evidence groups support NBIX, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 4 of 6Comparison trend: Reversed
NBIX

Neurocrine Biosciences, Inc.

Leads
AIQ Score
74/100
AIQ Edge Score
9/10
TSM

Taiwan Semiconductor Manufacturing Company Limited

AIQ Score
67/100
AIQ Edge Score
10/10

The Algovestiq AIQ Score currently favors NBIX over TSM, 74 versus 67 as of Nov 15, 2026. NBIX's advantage is driven primarily by stronger value and risk resilience. NBIX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors TSM. 4 of 6 covered evidence groups favor NBIX today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. NBIX lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; NBIX now leads by 7. NBIX leads on all four AIQ factor dimensions. Value is itself one of those four, so a sweep is not explained by valuation alone — it deserves additional scrutiny for unmodeled catalysts, expectations or event risk.

Compare Neurocrine Biosciences, Inc. and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

NBIX
+86.8%
TSM
+257.5%

Total return comparison

Growth of $10,000, distributions reinvested

NBIX $18,683 · TSM $35,753

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare NBIX and TSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

NBIX advantage
0
TSM advantage
  • Value77 vs 66
    NBIX +11
  • Risk Resilience69 vs 58
    NBIX +11
  • Quality79 vs 74
    NBIX +5
  • Momentum70 vs 66
    NBIX +4

4 of 6 evidence groups favor NBIX. NBIX’s edge is concentrated in value and risk resilience.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

NBIX0 AIQ

Largest factor move: Value +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.7%)
TSM0 AIQ

Largest factor move: Momentum +2, not enough on its own to move the overall score.

New signals

  • Price Lost 200-Day MA — bearish, trend, long horizon

NBIX's lead was unchanged in the latest session.

Deeper signal detail for each name lives on its own signals page — NBIX and TSM both carry a full feed there.

The central trade-off

NBIX (Neurocrine Biosciences, Inc.): the stronger current systematic profile, led by value and risk resilience.

TSM (Taiwan Semiconductor Manufacturing Company Limited): the counter-case, on analyst expectations — but at materially higher volatility, 61.7% against 55%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

NBIX

NBIX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

NBIX

NBIX on combined revenue and EPS growth.

Value

NBIX

NBIX on the peer-relative Value factor, by 11 points.

Momentum

NBIX

NBIX on the Momentum factor, by 4 points.

Lower downside

NBIX

NBIX on Risk Resilience, by 11 points.

Analyst upside

TSM

TSM on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors NBIX, analyst targets favor TSM. That disagreement is the most useful thing on this page.

MeasureNBIXTSMNote
Implied upside to target+23.5%+44.5%TSM has more room
Target dispersion+19.8%+26.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering2922Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

4 of 6 covered evidence groups favor NBIX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreNBIX74 vs 67
FundamentalsEvenrevenue growth 17.1% vs 17.6%; EPS growth 42% vs 8%; TTM ROE 5.3% vs 10.9%; gross margin 97.8% vs 65.8%; operating margin 23.8% vs 57.9%
ValuationNBIXValue 77 vs 66
TechnicalsNBIXPrice vs 50-day 12.7% vs -7.3%; vs 200-day 12.4% vs -1.1%
Risk ResilienceNBIXRisk Resilience 69 vs 58
Analyst expectationsTSMTarget upside 23.5% vs 44.5%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of NBIX and TSM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is moderate at 7 points.
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on NBIX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

NBIX lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; NBIX now leads by 7.

May 27NBIX leads above the line · TSM leads belowNov 13
Today
NBIX +7
74 vs 67
7 sessions ago
NBIX +3
71 vs 68
30 sessions ago
TSM +4
68 vs 72
90 sessions ago
NBIX +6
74 vs 68

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

NBIXConflicted

4 bullish / 2 bearish / 1 neutral, conflicted

Only NBIX

  • Death Cross Active — bearish, trend, long horizon (0.20%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.7%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • RSI Bearish Divergence — bearish, momentum, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
TSMConflicted

2 bullish / 2 bearish / 1 neutral, conflicted

Only TSM

  • Golden Cross Active — bullish, trend, long horizon (6.71%)
  • Price Lost 200-Day MA — bearish, trend, long horizon
  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (4.29%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

NBIX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

NBIXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.18%, AIQ 0 points).

TSMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.67%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1TSM closes the Value gap — currently 11 points behind, the largest single contributor to NBIX's edge.
  2. 2TSM's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it.
  3. 3NBIX's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricNBIXTSM
Revenue growth (YoY)17.1%17.6%
EPS growth (YoY)42%8%
Gross margin97.8%65.8%
Operating margin23.8%57.9%
Return on equity (TTM)5.3%10.9%
Debt to equity0.10.14

Performance

Split across windows
MetricNBIXTSM
1 week (5 sessions)1.7%6.2%
1 month (20 sessions)23.4%-3.4%
3 months (63 sessions)8.4%-7.5%
6 months (126 sessions)5.7%-1.4%
Year to date18%31.2%
1 year (252 sessions)14%37.2%

Technicals

NBIX has the stronger structure
MetricNBIXTSM
RSI (14)64.445.3
ADX (14)33.629.2
Price vs 50-day12.7%-7.3%
Price vs 200-day12.4%-1.1%
Volatility (1M, annualized)55%61.7%

Risk

NBIX is the more resilient
MetricNBIXTSM
Beta0.72.16
Sharpe ratio0.490.95
Sortino ratio0.721.37
Max drawdown-27.2%-27.3%
Current drawdown-9.8%-17.9%
Annualized volatility35.2%41.8%
Value at risk (95%)-3.4%-4.2%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, NBIX or TSM?

On the Algovestiq AIQ Score, NBIX is the stronger of the two as of Nov 15, 2026, scoring 74 against TSM's 67. The edge comes from value and risk resilience. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is NBIX or TSM the better buy right now?

NBIX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.

Why does the AIQ Score favor NBIX over TSM?

The composite weights Quality, Value, Momentum and Risk Resilience. NBIX leads Value by 11 points; NBIX leads Risk Resilience by 11 points; NBIX leads Quality by 5 points. NBIX leads on all four AIQ factor dimensions. Value is itself one of those four, so the sweep is not explained by TSM simply being cheaper — it warrants extra scrutiny for unmodeled catalysts, forward expectations or event risk the factors do not capture.

Which has more analyst upside, NBIX or TSM?

Analyst price targets imply +23.5% upside for NBIX and +44.5% for TSM, so the Street currently favors TSM. That points the opposite way to the AIQ Score, which favors NBIX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, NBIX or TSM?

NBIX is the better-valued of the two on the peer-relative Value factor. NBIX on the peer-relative Value factor, by 11 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, NBIX or TSM?

NBIX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, NBIX or TSM?

NBIX on the Momentum factor, by 4 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, NBIX or TSM?

NBIX is the more resilient of the two, so the other name carries the higher downside risk. NBIX on Risk Resilience, by 11 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is NBIX more profitable than TSM?

The profitability evidence is mixed: gross margin 97.8% vs 65.8%; operating margin 23.8% vs 57.9%; ttm roe 5.3% vs 10.9%. NBIX leads on one measure and TSM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is NBIX's lead over TSM getting stronger or weaker?

NBIX lead: Reversed — TSM led by 4 AIQ points 30 sessions ago; NBIX now leads by 7. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the NBIX vs TSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TSM closes the Value gap — currently 11 points behind, the largest single contributor to NBIX's edge; TSM's Price Lost 200-Day MA resolves — a bearish trend rule currently active against it; NBIX's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about NBIX and TSM?

NBIX: 4 bullish / 2 bearish / 1 neutral, conflicted. TSM: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NBIX is Death Cross Active (bearish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).

Compare NBIX and TSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.